Business · 22/04/2011Updated: 10/17/2026 · 1 min read

FDA Approves Supplemental New Animal Drug Application for Enrofloxacin Solution in Cattle

The FDA is updating its regulations to reflect the approval of a new animal drug application by Bayer HealthCare LLC, which allows for the use of enrofloxacin solution in cattle for treating respiratory disease. The new application adds a pathogen to the existing indications for use.